WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

  • Yumei Li
  • , Yu Zhou
  • , Bifei Li
  • , Fan Chen
  • , Weiyu Shen
  • , Yusheng Lu
  • , Chunlian Zhong
  • , Chen Zhang
  • , Huanzhang Xie
  • , Vladimir L. Katanaev
  • , Lee Jia*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

The key molecules and underlying mechanisms of melanoma metastasis remain poorly understood. Using isobaric tag for relative and absolute quantitation (iTRAQ) proteomic screening, probing of patients’ samples, functional verification, and mechanistic validation, we identified the important role of the WD repeat-containing protein 74 (WDR74) in melanoma progression and metastasis. Through gain- and loss-of-function approaches, WDR74 was found to promote cell proliferation, apoptosis resistance, and aggressive behavior in vitro. Moreover, WDR74 contributed to melanoma growth and metastasis in vivo. Mechanistically, WDR74 modulates RPL5 protein levels and consequently regulates MDM2 and insulates the ubiquitination degradation of p53 by MDM2. Our study is the first to reveal the oncogenic role of WDR74 in melanoma progression and the regulatory effect of WDR74 on the RPL5–MDM2-p53 pathway. Collectively, WDR74 can serve as a candidate target for the prevention and treatment of melanoma in the clinic.

Original languageEnglish
Pages (from-to)2741-2755
Number of pages15
JournalOncogene
Volume39
Issue number13
DOIs
Publication statusPublished - 26 Mar 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway'. Together they form a unique fingerprint.

Cite this